Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
Journal: Journal of affective disorders
Published: December 24, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
Journal: Journal of affective disorders
Published: October 11, 2025
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
Journal: The Journal of clinical psychiatry
Published: March 06, 2025
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Journal: Journal of affective disorders
Published: August 01, 2024
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.
Journal: Journal of psychiatric research
Published: May 24, 2024
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Journal: Journal of affective disorders
Published: December 16, 2022
M1-muscarinic receptors promote fear memory consolidation via phospholipase C and the M-current.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: January 31, 2014
Redundant catecholamine signaling consolidates fear memory via phospholipase C.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: February 11, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026